ǥ :
|
ȣ - 520304 212 |
Uric Acid As Prognostic Marker in Advanced Non-Ischemic Dilated Cardiomyopathy: Comparison with NT-ProBNP Level |
계명대학교 동산의료원 심장내과 |
김형섭, 김수연, 김기민, 신홍원, 김현태, 김인철, 전동환, 조윤경, 박형섭, 윤혁준, 남창욱, 한성욱, 허승호, 김윤년, 김권배 |
Background Although uric acid (UA) has been associated with an increased risk of cardiovascular events, it is unclear whether UA can provide greater prognostic information than N-terminal pro B-type natriuretic peptide (NT-ProBNP) in advanced heart failure with non-ischemic dilated cardiomyopathy (DCM).
Method A total of 83 DCM patients (mean age 62 years, mean ejection fraction 27%) were evaluated with echocardiography. UA and NT-ProBNP were measured. Development of clinical events during follow-up was defined as the composite of cardiac death and admission for recurrent heart failure.
Results During follow-up (mean 17 months), there were 15 cardiac events(1 death, 14 recurrent heart failure). In patients with cardiac events, UA and NT-ProBNP were significantly higher than in event-free patients. The receiver-operating characteristics curve for determining cut-off values of UA and NT-ProBNP for prognosis showed that the area under the curve for UA was greater (0.83, 95% CI 0.721-0.945) than that for NT-ProBNP (0.66, 95% CI 0.541-0.786). On multivariate Cox analysis, UA remained the only independent predictor for prognosis. Furthermore, UA≥9 mg/dL rather than NT-ProBNP≥3,500 pg/mL were associated with decreased cardiac event-free survival (log rank chi square=28.4 and 9.8; p<0.001, and p=0.002, respectively).
Conclusion UA could be a prognostic predictor in patients with non-ischemic DCM and more informative than NT-ProBNP.
|
|
Warning: getimagesize(/home/virtual/circulationadmin/renewal/econgress/conference/abstract/img_files/CombinationFigure-final복사.jpg) [function.getimagesize]: failed to open stream: No such file or directory in /home/virtual/circulationadmin/new/econgress/conference/manage/schedule/view_abstract.php on line 164
|
|